treatments

Pioneering collaboration initiated by the University of Cambridge, Imperial College London and University College London

Nanobots that patrol our bodies, killer immune cells hunting and destroying cancer cells, biological scissors that cut out defective genes: these are...

Tony Kouzarides is passionate about ecosystems: well-balanced communities that flourish on mutual and dynamic interactions. But the ecosystems that...

The stirrings of a revolution are starting to ripple through hundreds of laboratories. It’s a revolution that aims to result in new medicines – faster...

Researchers are working with pharmaceutical companies to make improvements across the whole supply chain, from how a pill is made to the moment it is...

How will precision medicine define 21st-century therapeutics? What will future healthcare look like? And what actually lies ‘beyond the pill’...

Craniectomy – a surgical procedure in which part of the skull is removed to relieve brain swelling – significantly reduces the risk of death following...

Tailored, targeted treatment for patients with oesophageal cancer could be developed after scientists discovered that the disease can be classified...

The Cambridge Animal Alphabet series celebrates Cambridge's connections with animals through literature, art, science and society. Here, Z is for...

The Cambridge Animal Alphabet series celebrates Cambridge's connections with animals through literature, art, science and society. Here, T is for...

A new genetic study of over 200,000 women reveals the underlying mechanisms of polycystic ovary syndrome, as well as potential interventions.

Graham Ladds, lecturer in pharmacology, discusses the controversy around a group of drugs used to treat Type 2 diabetes.